-
This year's version of H3N2 has experts on alert. It's a mutated version, subclade K, that may weaken the vaccine's protection, but makes getting vaccinated more important than ever.
-
A San Antonio doctor who uses endoscopy to treat people who are too sick to survive surgery has become the first Texan to be named a Master Endoscopist by the American Society for Gastrointestinal Endoscopy.
-
A San Antonio sleep disorder and PTSD researcher uses cognitive behavioral therapy to reduce the frequency and intensity of nightmares.
-
The 103,000-square-foot facility is the new home of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases.
-
A San Antonio scientist thinks of the protein that drives most prostate cancers as a machine, and pioneers a method to visualize it for the first time. This could lead to much better treatments and, someday, prevention.
-
Malaria kills more than half a million people a year, and an effective vaccine has been elusive. But a San Antonio malaria researcher and her team have discovered a vulnerability in the malaria parasite's method of avoiding the human immune system that may make all the difference.
-
An anti-aging medication called rapamycin seems to work better in female mice than in males, and it's the only one studied as part of the National Institute of Aging's Interventions Testing Program to do so. Most of the medications singled out for their effectiveness in a recent review only work in male mice.
-
The UT Health San Antonio professor who is leading an effort to increase the number of South Texas teens who are vaccinated against the human papillomavirus hopes to see cervical cancer eliminated in the United States in her lifetime.
-
MCAM is a long-acting medication that can prevent opioid overdose by blocking the effects of opioids for days or even weeks.
-
Occupational therapy can help people with mental illness resume meaningful activities in their lives and create strategies that will improve their overall health. A San Antonio OT has developed a program she hopes will help people with a mental illness and type 2 diabetes achieve better control over their disease.